| HOME >> MEDICINE >> TECHNOLOGY |
135.5119.2Rental
55.965.9Total gross profit
191.4185.1As a percentage of sales
44.7%48.6%Research and development expenses
17.215.3Selling and administrative expenses
136.1120.2Litigation charge
1.0-Operating profit37.149.6Other income/(expense), net
(1.8)(1.2)Income tax expense
11.315.5Net income $
24.0$
32.9Diluted earnings per share:Earnings per share
$
.39$
.53Average common shares outstanding - diluted (thousands)61,10662,337Dividends per common share$0.1250$0.1125Non-GAAP Financial Disclosures and ReconciliationsWhile Hill-Rom reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Hill-Rom uses the non-GAAP measures to evaluate and manage its operations and provides the information to assist investors in performing financial analysis that is consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. Hill-Rom Holdings, Inc. and SubsidiariesRevenues - Constant Currency(Dollars in millions)Quarter Ended December 312012Foreign Exchange 20122011Constant CurrencyAs ReportedImpactAdjustedAs ReportedChangeCapital sales
$
324.4$
(1.7)$ 326.1$
266.922.2%Rental revenues
104.0(0.2)104.2114.2-8.8%Total$
428.4$
(1.9)$ 430.3$
381.112.9%North America
$
234.7$
.3$ 234.4$
252.4-7.1%Surgical and Respiratory Care
59.00.158.932.084.1%International
134.7(2.3)137.096.741.7%Total $
428.4$
(1.9)$ 430.3$
381.112.9% Hill-Rom Holdings, Inc. and SubsidiariesReconciliation: E
'/>"/>
| SOURCE Hill-Rom Holdings, Inc. Copyright©2012 PR Newswire. All rights reserved |